Reported Standalone quarterly numbers for Sangam Health Care Products are:Net Sales at Rs 3.71 crore in December 2021 up 64.03% from Rs. 2.26 crore in December 2020.
Quarterly Net Loss at Rs. 1.24 crore in December 2021 up 55.87% from Rs. 2.82 crore in December 2020.
EBITDA stands negative at Rs. 0.86 crore in December 2021 up 65.6% from Rs. 2.50 crore in December 2020.
| Sangam Health Care Products | | Standalone Quarterly Results | in Rs. Cr. |
|
| Dec'21 | Sep'21 | Dec'20 | | Net Sales/Income from operations | 3.71 | 0.88 | 2.26 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 3.71 | 0.88 | 2.26 | | EXPENDITURE | | Consumption of Raw Materials | 3.09 | 0.88 | 0.84 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -0.30 | -0.26 | -0.04 | | Power & Fuel | -- | -- | -- | | Employees Cost | 0.97 | 0.01 | 3.30 | | Depreciation | 0.28 | 0.28 | 0.31 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 0.88 | 0.31 | 0.66 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -1.21 | -0.32 | -2.81 | | Other Income | 0.07 | -- | -- | | P/L Before Int., Excpt. Items & Tax | -1.14 | -0.32 | -2.81 | | Interest | 0.10 | 0.00 | 0.01 | | P/L Before Exceptional Items & Tax | -1.24 | -0.33 | -2.82 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -1.24 | -0.33 | -2.82 | | Tax | -- | -- | -- | | P/L After Tax from Ordinary Activities | -1.24 | -0.33 | -2.82 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -1.24 | -0.33 | -2.82 | | Equity Share Capital | 14.86 | 14.86 | 14.86 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -0.84 | -0.22 | -1.90 | | Diluted EPS | -0.84 | -0.22 | -1.90 | | EPS After Extra Ordinary | | Basic EPS | -0.84 | -0.22 | -1.90 | | Diluted EPS | -0.84 | -0.22 | -1.90 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
